Wenger Frank Axel, Kilian Maik, Heukamp Ina, Foitzik Thomas, Jacobi Christoph Andreas, Guski Hans, Schimke Ingolf, Müller Joachim Michael
Clinic of Surgery and Center of Minimal-Invasive Surgery, Kliniken Essen-Mitte, Essen, Germany.
J Gastroenterol Hepatol. 2007 Nov;22(11):1872-6. doi: 10.1111/j.1440-1746.2006.04627.x.
Octreotide is considered to reduce exocrine pancreatic secretion in acute hemorrhagic necrotizing pancreatitis decreasing pancreatic autodigestion. The aim of this study was to determine whether octreotide also has antioxidative effects in acute pancreatitis. Additionally time and dose of application were of interest.
Ninety male Sprague-Dawley rats were randomized into six groups (n = 15). Group 1 underwent a laparotomy, and animals in groups 2-6 received intraductal glycodeoxycholic acid followed by intravenous cerulein. Groups 3 and 4 were injected with 0.5 mg octreotide, while groups 5 and 6 received continuous intravenous infusion of 0.05 mg octreotide/h for 10 h. Treatment was initiated 6 hours after induction of pancreatitis (IP) in groups 3 and 5, and 14 h after IP in groups 4 and 6. At 24 h after IP all animals were killed and each pancreas was analyzed histopathologically. In addition, levels of pancreatic lipid peroxidation protective enzymes glutathione-peroxidase (GSH-Px) and superoxide dismutase (SOD) as well as lipid peroxidation via thiobarbituric acid reactive substances (TBARS) were determined.
Early bolus application of octreotide reduced severity of histopathological changes in acute pancreatitis and decreased lipid peroxidation in pancreatic tissue samples; however, late bolus application and continuous intravenous infusion did not influence pancreatitis or lipid peroxidation.
Octreotide seems to have a dose- and time-dependent effect on histopathology and lipid peroxidation in a model of pancreatitis in rats.
奥曲肽被认为可减少急性出血性坏死性胰腺炎时胰腺外分泌,减少胰腺自身消化。本研究旨在确定奥曲肽在急性胰腺炎中是否也具有抗氧化作用。此外,应用的时间和剂量也备受关注。
将90只雄性Sprague-Dawley大鼠随机分为6组(每组n = 15)。第1组接受剖腹手术,第2 - 6组大鼠经导管注入甘氨脱氧胆酸,随后静脉注射雨蛙素。第3组和第4组注射0.5 mg奥曲肽,而第5组和第6组以0.05 mg/h的速度持续静脉输注奥曲肽10小时。在胰腺炎诱导后6小时(IP),第3组和第5组开始治疗;在IP后14小时,第4组和第6组开始治疗。IP后24小时处死所有动物,对每个胰腺进行组织病理学分析。此外,还测定了胰腺脂质过氧化保护酶谷胱甘肽过氧化物酶(GSH-Px)和超氧化物歧化酶(SOD)的水平,以及通过硫代巴比妥酸反应性物质(TBARS)测定的脂质过氧化水平。
早期推注奥曲肽可减轻急性胰腺炎组织病理学变化的严重程度,并降低胰腺组织样本中的脂质过氧化;然而,晚期推注和持续静脉输注对胰腺炎或脂质过氧化没有影响。
在大鼠胰腺炎模型中,奥曲肽似乎对组织病理学和脂质过氧化具有剂量和时间依赖性效应。